| 1 | washout | 2,219 |
| 2 | titration | 1,587 |
| 3 | run-in | 1,290 |
| 4 | escalation | 777 |
| 5 | wash-out | 404 |
| 6 | lead-in | 318 |
| 7 | pre-ejection | 239 |
| 8 | dependently | 182 |
| 9 | preejection | 169 |
| 10 | detraining | 159 |
| 11 | proportionality | 135 |
| 12 | up-titration | 117 |
| 13 | point-prevalence | 101 |
| 14 | familiarization | 91 |
| 15 | dose-titration | 52 |
| 16 | lockout | 50 |
| 17 | hiking | 35 |
| 18 | co-synch | 30 |
| 19 | depuration | 30 |
| 20 | blanking | 29 |
| 21 | escalations | 26 |
| 22 | chase | 23 |
| 23 | off-drug | 23 |
| 24 | dose-adjustment | 19 |
| 25 | prepatent | 19 |
| 26 | jhg | 17 |
| 27 | republican | 17 |
| 28 | cool-down | 16 |
| 29 | diet/placebo | 15 |
| 30 | precessation | 15 |
| 31 | preindex | 15 |
| 32 | run-out | 15 |
| 33 | standby | 15 |
| 34 | postindex | 14 |
| 35 | wash-in | 14 |
| 36 | down-titration | 13 |
| 37 | pill-free | 13 |
| 38 | variable-dose | 12 |
| 39 | fall-off | 11 |
| 40 | fixed-dosing | 10 |
| 41 | dose-maintenance | 8 |
| 42 | non-brushing | 8 |
| 43 | qfxbf | 8 |
| 44 | range-finding | 8 |
| 45 | tablet-free | 8 |
| 46 | 'sensitive | 7 |
| 47 | diet-placebo | 7 |
| 48 | preconversion | 7 |
| 49 | tzpg | 7 |
| 50 | dysphagia-free | 6 |
| 51 | screening/baseline | 6 |
| 52 | steroid-stable | 6 |
| 53 | incentivization | 5 |
| 54 | non-epidemic | 5 |
| 55 | peri-ovulatory | 5 |
| 56 | preprolapse | 5 |
| 57 | yom | 5 |
| 58 | bionic-pancreas | 4 |
| 59 | clmp | 4 |
| 60 | diet+placebo | 4 |
| 61 | n-balance | 4 |
| 62 | non-heating | 4 |
| 63 | placebo-washout | 4 |
| 64 | post-soviet | 4 |
| 65 | postpolicy | 4 |
| 66 | pre-departure | 4 |
| 67 | prepolicy | 4 |
| 68 | sign-up | 4 |
| 69 | switch-back | 4 |
| 70 | titration/conversion | 4 |
| 71 | 1,500mg | 3 |
| 72 | birth-spacing | 3 |
| 73 | clofazimine-containing | 3 |
| 74 | down-taper | 3 |
| 75 | gestational/weaning | 3 |
| 76 | id-st | 3 |
| 77 | inter-dose | 3 |
| 78 | internatal | 3 |
| 79 | medicine-free | 3 |
| 80 | post-fumigation | 3 |
| 81 | ppi/a/c | 3 |
| 82 | rikkunshito-on | 3 |
| 83 | screening/washout | 3 |
| 84 | softad | 3 |
| 85 | treatment-extension | 3 |
| 86 | vlcd/lcd | 3 |
| 87 | withdrawal-retreatment | 3 |
| 88 | 12mg/day | 2 |
| 89 | 63-dim | 2 |
| 90 | 68gy | 2 |
| 91 | bismuth-lansoprazole-amoxicillin-clarithromycin | 2 |
| 92 | clean-out | 2 |
| 93 | conversion/titration | 2 |
| 94 | dose-determining | 2 |
| 95 | dose-tapering | 2 |
| 96 | drug-discontinuation/tapering | 2 |
| 97 | drug-washout | 2 |
| 98 | eot-pp | 2 |
| 99 | esl+oc | 2 |
| 100 | heating-up | 2 |
| 101 | honeymoon | 2 |
| 102 | hormone-treatment | 2 |
| 103 | insoluble-fiber | 2 |
| 104 | interval.the | 2 |
| 105 | low-calorie-diet | 2 |
| 106 | mindfulness-training | 2 |
| 107 | neogene | 2 |
| 108 | no-hygiene | 2 |
| 109 | observation/retreatment | 2 |
| 110 | off-prophylaxis | 2 |
| 111 | omeprazole-clarithromycin-metronidazole | 2 |
| 112 | on/off/on | 2 |
| 113 | p4+pgf2α | 2 |
| 114 | peri-intubation | 2 |
| 115 | periextubation | 2 |
| 116 | phase-in | 2 |
| 117 | placebo-baseline | 2 |
| 118 | placebo/dietary | 2 |
| 119 | post-distribution | 2 |
| 120 | post-titration | 2 |
| 121 | postcolonoscopy | 2 |
| 122 | postdetailing | 2 |
| 123 | postmethylphenidate | 2 |
| 124 | postoptimization | 2 |
| 125 | pre-eradication | 2 |
| 126 | precontrol | 2 |
| 127 | rewatering | 2 |
| 128 | rikkunshito-off | 2 |
| 129 | ring-free | 2 |
| 130 | run-in/screening | 2 |
| 131 | run-in/washout | 2 |
| 132 | soy-diet | 2 |
| 133 | thie | 2 |
| 134 | trimethoprim-sulfadiazine | 2 |
| 135 | videotape/dvd | 2 |
| 136 | warmth/heat | 2 |
| 137 | washout/dietary | 2 |
| 138 | ''safe | 1 |
| 139 | -proportional | 1 |
| 140 | 1-3-month | 1 |
| 141 | 1-6-month | 1 |
| 142 | 10-mg/kg/day | 1 |
| 143 | 12-24-month | 1 |
| 144 | 12-month-observation | 1 |
| 145 | 16-mo | 1 |
| 146 | 162-km | 1 |
| 147 | 1968-71 | 1 |
| 148 | 1970-1989 | 1 |
| 149 | 2-3-month | 1 |
| 150 | 2/3-year | 1 |
| 151 | 20+/-10mg/day | 1 |
| 152 | 200/day | 1 |
| 153 | 24-72-h | 1 |
| 154 | 30-day-observation | 1 |
| 155 | 35-yr | 1 |
| 156 | 480-min | 1 |
| 157 | 4mg/100g | 1 |
| 158 | 55minute | 1 |
| 159 | 74.4gy | 1 |
| 160 | actuations/24-h | 1 |
| 161 | andapplication | 1 |
| 162 | apr-jul | 1 |
| 163 | aware® | 1 |
| 164 | bare-fallow | 1 |
| 165 | baseline-1 | 1 |
| 166 | biopsy-to-excision | 1 |
| 167 | bite-increase | 1 |
| 168 | calcipotrial | 1 |
| 169 | changes/interruptions | 1 |
| 170 | cidr-co-synch | 1 |
| 171 | clonazepam-free | 1 |
| 172 | coach-administered | 1 |
| 173 | continuation/escalation | 1 |
| 174 | contraction-free | 1 |
| 175 | csa/corticosteroid | 1 |
| 176 | de-lithiation | 1 |
| 177 | dependent-manner | 1 |
| 178 | diet-free | 1 |
| 179 | diet-plus-placebo | 1 |
| 180 | diet/stabilisation | 1 |
| 181 | dlt-defining | 1 |
| 182 | dose-ramp | 1 |
| 183 | during-apheresis | 1 |
| 184 | dynastic | 1 |
| 185 | efficacy-assessment | 1 |
| 186 | eligibility/study | 1 |
| 187 | embryonation | 1 |
| 188 | escalation/expansion | 1 |
| 189 | exposures-when | 1 |
| 190 | fatigue-adapted | 1 |
| 191 | feed-deprivation | 1 |
| 192 | first-interovulatory | 1 |
| 193 | flow-up | 1 |
| 194 | fluticasone-reduction | 1 |
| 195 | fq-containing | 1 |
| 196 | fructose-loading | 1 |
| 197 | fumigating | 1 |
| 198 | gym- | 1 |
| 199 | h=1355±51 | 1 |
| 200 | high-loading | 1 |
| 201 | ifn-γ-priming | 1 |
| 202 | index-volume | 1 |
| 203 | infant-priming | 1 |
| 204 | injection-free | 1 |
| 205 | interdosing | 1 |
| 206 | interexacerbation | 1 |
| 207 | interruptions/adjustments | 1 |
| 208 | intershock | 1 |
| 209 | labilisation | 1 |
| 210 | lag/time | 1 |
| 211 | last-known-well | 1 |
| 212 | lavastatin | 1 |
| 213 | leadin | 1 |
| 214 | left/cathodal | 1 |
| 215 | leuteal | 1 |
| 216 | lipid-stabilization | 1 |
| 217 | mini-volume | 1 |
| 218 | moche | 1 |
| 219 | modification/withholding | 1 |
| 220 | modifications/delays | 1 |
| 221 | mono-injection | 1 |
| 222 | month-run-in | 1 |
| 223 | non-cleaning | 1 |
| 224 | noninfusion | 1 |
| 225 | ofcefotaxime | 1 |
| 226 | off-cpb | 1 |
| 227 | ofprednisolone | 1 |
| 228 | omeprazole-bismuth-tetracycline-metronidazole | 1 |
| 229 | one-month-follow-up | 1 |
| 230 | only-one | 1 |
| 231 | paracetamol/nsaids | 1 |
| 232 | patch-on | 1 |
| 233 | pegylated-ifnα | 1 |
| 234 | peri-/postmenopausal | 1 |
| 235 | peri-lt | 1 |
| 236 | peri-luteolysis | 1 |
| 237 | peri-training | 1 |
| 238 | peri-transplantation | 1 |
| 239 | pericraniotomy | 1 |
| 240 | period.twenty-one | 1 |
| 241 | periopeartive | 1 |
| 242 | perioperational | 1 |
| 243 | peritransfusion | 1 |
| 244 | pinteraction=0·002 | 1 |
| 245 | pinteraction=0·85 | 1 |
| 246 | pinteraction=0·99 | 1 |
| 247 | plaster-on/plaster-off | 1 |
| 248 | pluvial | 1 |
| 249 | pneumonitic | 1 |
| 250 | post-adenomectomy | 1 |
| 251 | post-asccp | 1 |
| 252 | post-contact | 1 |
| 253 | post-enteritic | 1 |
| 254 | post-follow-up | 1 |
| 255 | post-revolutionary | 1 |
| 256 | post-surgical/post-rtms | 1 |
| 257 | post-trh | 1 |
| 258 | post-warning | 1 |
| 259 | postblanking | 1 |
| 260 | postcall | 1 |
| 261 | postdrink | 1 |
| 262 | postline | 1 |
| 263 | postmixing | 1 |
| 264 | postprophylaxis | 1 |
| 265 | postrejection | 1 |
| 266 | postsplenectomy | 1 |
| 267 | ppi-clarithromycin-levofloxacin | 1 |
| 268 | ppi-containing | 1 |
| 269 | pre-ban | 1 |
| 270 | pre-bloom | 1 |
| 271 | pre-ejection/ejection | 1 |
| 272 | pre-ejectional | 1 |
| 273 | pre-lambing | 1 |
| 274 | pre-mua | 1 |
| 275 | pre-omt | 1 |
| 276 | pre-pcv7 | 1 |
| 277 | pre-running | 1 |
| 278 | pre-tcm | 1 |
| 279 | pre-verapamil | 1 |
| 280 | pre-wean | 1 |
| 281 | pre-wildfire | 1 |
| 282 | prebonding | 1 |
| 283 | predawn | 1 |
| 284 | preejectional | 1 |
| 285 | pregnant-puerperal | 1 |
| 286 | prenatal-postpartum | 1 |
| 287 | preoviposition | 1 |
| 288 | prestudy/run-in | 1 |
| 289 | randomized-treatment | 1 |
| 290 | ranging/efficacy/safety | 1 |
| 291 | rbc-clarithromycin-amoxicillin | 1 |
| 292 | re-titration | 1 |
| 293 | reduction.severity | 1 |
| 294 | reductions/interruptions | 1 |
| 295 | regimens-one | 1 |
| 296 | rest/absorption | 1 |
| 297 | reversed-conditioning | 1 |
| 298 | running-out | 1 |
| 299 | side-clamp | 1 |
| 300 | slave-trading | 1 |
| 301 | smartphone-intervention | 1 |
| 302 | sparings | 1 |
| 303 | sprinolactone | 1 |
| 304 | stabilisation/screening | 1 |
| 305 | subpatent | 1 |
| 306 | suckling/growing | 1 |
| 307 | survival-free | 1 |
| 308 | taper/washout | 1 |
| 309 | tapering/initiation | 1 |
| 310 | tapering/washout | 1 |
| 311 | therapy-augmenting | 1 |
| 312 | therapy.superiority | 1 |
| 313 | therapy/waiting | 1 |
| 314 | titraters | 1 |
| 315 | titration/stabilization | 1 |
| 316 | tolerability-assessment | 1 |
| 317 | tot-elicitation | 1 |
| 318 | voriconazole-only | 1 |
| 319 | wash-out-single-blind | 1 |
| 320 | wash-outs | 1 |
| 321 | washout/run-in | 1 |
| 322 | washover | 1 |
| 1 | ''safe | 1 |
| 2 | 'sensitive | 7 |
| 3 | -proportional | 1 |
| 4 | 1,500mg | 3 |
| 5 | 1-3-month | 1 |
| 6 | 1-6-month | 1 |
| 7 | 10-mg/kg/day | 1 |
| 8 | 12-24-month | 1 |
| 9 | 12-month-observation | 1 |
| 10 | 12mg/day | 2 |
| 11 | 16-mo | 1 |
| 12 | 162-km | 1 |
| 13 | 1968-71 | 1 |
| 14 | 1970-1989 | 1 |
| 15 | 2-3-month | 1 |
| 16 | 2/3-year | 1 |
| 17 | 20+/-10mg/day | 1 |
| 18 | 200/day | 1 |
| 19 | 24-72-h | 1 |
| 20 | 30-day-observation | 1 |
| 21 | 35-yr | 1 |
| 22 | 480-min | 1 |
| 23 | 4mg/100g | 1 |
| 24 | 55minute | 1 |
| 25 | 63-dim | 2 |
| 26 | 68gy | 2 |
| 27 | 74.4gy | 1 |
| 28 | actuations/24-h | 1 |
| 29 | andapplication | 1 |
| 30 | apr-jul | 1 |
| 31 | aware® | 1 |
| 32 | bare-fallow | 1 |
| 33 | baseline-1 | 1 |
| 34 | bionic-pancreas | 4 |
| 35 | biopsy-to-excision | 1 |
| 36 | birth-spacing | 3 |
| 37 | bismuth-lansoprazole-amoxicillin-clarithromycin | 2 |
| 38 | bite-increase | 1 |
| 39 | blanking | 29 |
| 40 | calcipotrial | 1 |
| 41 | changes/interruptions | 1 |
| 42 | chase | 23 |
| 43 | cidr-co-synch | 1 |
| 44 | clean-out | 2 |
| 45 | clmp | 4 |
| 46 | clofazimine-containing | 3 |
| 47 | clonazepam-free | 1 |
| 48 | co-synch | 30 |
| 49 | coach-administered | 1 |
| 50 | continuation/escalation | 1 |
| 51 | contraction-free | 1 |
| 52 | conversion/titration | 2 |
| 53 | cool-down | 16 |
| 54 | csa/corticosteroid | 1 |
| 55 | de-lithiation | 1 |
| 56 | dependent-manner | 1 |
| 57 | dependently | 182 |
| 58 | depuration | 30 |
| 59 | detraining | 159 |
| 60 | diet+placebo | 4 |
| 61 | diet-free | 1 |
| 62 | diet-placebo | 7 |
| 63 | diet-plus-placebo | 1 |
| 64 | diet/placebo | 15 |
| 65 | diet/stabilisation | 1 |
| 66 | dlt-defining | 1 |
| 67 | dose-adjustment | 19 |
| 68 | dose-determining | 2 |
| 69 | dose-maintenance | 8 |
| 70 | dose-ramp | 1 |
| 71 | dose-tapering | 2 |
| 72 | dose-titration | 52 |
| 73 | down-taper | 3 |
| 74 | down-titration | 13 |
| 75 | drug-discontinuation/tapering | 2 |
| 76 | drug-washout | 2 |
| 77 | during-apheresis | 1 |
| 78 | dynastic | 1 |
| 79 | dysphagia-free | 6 |
| 80 | efficacy-assessment | 1 |
| 81 | eligibility/study | 1 |
| 82 | embryonation | 1 |
| 83 | eot-pp | 2 |
| 84 | escalation | 777 |
| 85 | escalation/expansion | 1 |
| 86 | escalations | 26 |
| 87 | esl+oc | 2 |
| 88 | exposures-when | 1 |
| 89 | fall-off | 11 |
| 90 | familiarization | 91 |
| 91 | fatigue-adapted | 1 |
| 92 | feed-deprivation | 1 |
| 93 | first-interovulatory | 1 |
| 94 | fixed-dosing | 10 |
| 95 | flow-up | 1 |
| 96 | fluticasone-reduction | 1 |
| 97 | fq-containing | 1 |
| 98 | fructose-loading | 1 |
| 99 | fumigating | 1 |
| 100 | gestational/weaning | 3 |
| 101 | gym- | 1 |
| 102 | h=1355±51 | 1 |
| 103 | heating-up | 2 |
| 104 | high-loading | 1 |
| 105 | hiking | 35 |
| 106 | honeymoon | 2 |
| 107 | hormone-treatment | 2 |
| 108 | id-st | 3 |
| 109 | ifn-γ-priming | 1 |
| 110 | incentivization | 5 |
| 111 | index-volume | 1 |
| 112 | infant-priming | 1 |
| 113 | injection-free | 1 |
| 114 | insoluble-fiber | 2 |
| 115 | inter-dose | 3 |
| 116 | interdosing | 1 |
| 117 | interexacerbation | 1 |
| 118 | internatal | 3 |
| 119 | interruptions/adjustments | 1 |
| 120 | intershock | 1 |
| 121 | interval.the | 2 |
| 122 | jhg | 17 |
| 123 | labilisation | 1 |
| 124 | lag/time | 1 |
| 125 | last-known-well | 1 |
| 126 | lavastatin | 1 |
| 127 | lead-in | 318 |
| 128 | leadin | 1 |
| 129 | left/cathodal | 1 |
| 130 | leuteal | 1 |
| 131 | lipid-stabilization | 1 |
| 132 | lockout | 50 |
| 133 | low-calorie-diet | 2 |
| 134 | medicine-free | 3 |
| 135 | mindfulness-training | 2 |
| 136 | mini-volume | 1 |
| 137 | moche | 1 |
| 138 | modification/withholding | 1 |
| 139 | modifications/delays | 1 |
| 140 | mono-injection | 1 |
| 141 | month-run-in | 1 |
| 142 | n-balance | 4 |
| 143 | neogene | 2 |
| 144 | no-hygiene | 2 |
| 145 | non-brushing | 8 |
| 146 | non-cleaning | 1 |
| 147 | non-epidemic | 5 |
| 148 | non-heating | 4 |
| 149 | noninfusion | 1 |
| 150 | observation/retreatment | 2 |
| 151 | ofcefotaxime | 1 |
| 152 | off-cpb | 1 |
| 153 | off-drug | 23 |
| 154 | off-prophylaxis | 2 |
| 155 | ofprednisolone | 1 |
| 156 | omeprazole-bismuth-tetracycline-metronidazole | 1 |
| 157 | omeprazole-clarithromycin-metronidazole | 2 |
| 158 | on/off/on | 2 |
| 159 | one-month-follow-up | 1 |
| 160 | only-one | 1 |
| 161 | p4+pgf2α | 2 |
| 162 | paracetamol/nsaids | 1 |
| 163 | patch-on | 1 |
| 164 | pegylated-ifnα | 1 |
| 165 | peri-/postmenopausal | 1 |
| 166 | peri-intubation | 2 |
| 167 | peri-lt | 1 |
| 168 | peri-luteolysis | 1 |
| 169 | peri-ovulatory | 5 |
| 170 | peri-training | 1 |
| 171 | peri-transplantation | 1 |
| 172 | pericraniotomy | 1 |
| 173 | periextubation | 2 |
| 174 | period.twenty-one | 1 |
| 175 | periopeartive | 1 |
| 176 | perioperational | 1 |
| 177 | peritransfusion | 1 |
| 178 | phase-in | 2 |
| 179 | pill-free | 13 |
| 180 | pinteraction=0·002 | 1 |
| 181 | pinteraction=0·85 | 1 |
| 182 | pinteraction=0·99 | 1 |
| 183 | placebo-baseline | 2 |
| 184 | placebo-washout | 4 |
| 185 | placebo/dietary | 2 |
| 186 | plaster-on/plaster-off | 1 |
| 187 | pluvial | 1 |
| 188 | pneumonitic | 1 |
| 189 | point-prevalence | 101 |
| 190 | post-adenomectomy | 1 |
| 191 | post-asccp | 1 |
| 192 | post-contact | 1 |
| 193 | post-distribution | 2 |
| 194 | post-enteritic | 1 |
| 195 | post-follow-up | 1 |
| 196 | post-fumigation | 3 |
| 197 | post-revolutionary | 1 |
| 198 | post-soviet | 4 |
| 199 | post-surgical/post-rtms | 1 |
| 200 | post-titration | 2 |
| 201 | post-trh | 1 |
| 202 | post-warning | 1 |
| 203 | postblanking | 1 |
| 204 | postcall | 1 |
| 205 | postcolonoscopy | 2 |
| 206 | postdetailing | 2 |
| 207 | postdrink | 1 |
| 208 | postindex | 14 |
| 209 | postline | 1 |
| 210 | postmethylphenidate | 2 |
| 211 | postmixing | 1 |
| 212 | postoptimization | 2 |
| 213 | postpolicy | 4 |
| 214 | postprophylaxis | 1 |
| 215 | postrejection | 1 |
| 216 | postsplenectomy | 1 |
| 217 | ppi-clarithromycin-levofloxacin | 1 |
| 218 | ppi-containing | 1 |
| 219 | ppi/a/c | 3 |
| 220 | pre-ban | 1 |
| 221 | pre-bloom | 1 |
| 222 | pre-departure | 4 |
| 223 | pre-ejection | 239 |
| 224 | pre-ejection/ejection | 1 |
| 225 | pre-ejectional | 1 |
| 226 | pre-eradication | 2 |
| 227 | pre-lambing | 1 |
| 228 | pre-mua | 1 |
| 229 | pre-omt | 1 |
| 230 | pre-pcv7 | 1 |
| 231 | pre-running | 1 |
| 232 | pre-tcm | 1 |
| 233 | pre-verapamil | 1 |
| 234 | pre-wean | 1 |
| 235 | pre-wildfire | 1 |
| 236 | prebonding | 1 |
| 237 | precessation | 15 |
| 238 | precontrol | 2 |
| 239 | preconversion | 7 |
| 240 | predawn | 1 |
| 241 | preejection | 169 |
| 242 | preejectional | 1 |
| 243 | pregnant-puerperal | 1 |
| 244 | preindex | 15 |
| 245 | prenatal-postpartum | 1 |
| 246 | preoviposition | 1 |
| 247 | prepatent | 19 |
| 248 | prepolicy | 4 |
| 249 | preprolapse | 5 |
| 250 | prestudy/run-in | 1 |
| 251 | proportionality | 135 |
| 252 | qfxbf | 8 |
| 253 | randomized-treatment | 1 |
| 254 | range-finding | 8 |
| 255 | ranging/efficacy/safety | 1 |
| 256 | rbc-clarithromycin-amoxicillin | 1 |
| 257 | re-titration | 1 |
| 258 | reduction.severity | 1 |
| 259 | reductions/interruptions | 1 |
| 260 | regimens-one | 1 |
| 261 | republican | 17 |
| 262 | rest/absorption | 1 |
| 263 | reversed-conditioning | 1 |
| 264 | rewatering | 2 |
| 265 | rikkunshito-off | 2 |
| 266 | rikkunshito-on | 3 |
| 267 | ring-free | 2 |
| 268 | run-in | 1,290 |
| 269 | run-in/screening | 2 |
| 270 | run-in/washout | 2 |
| 271 | run-out | 15 |
| 272 | running-out | 1 |
| 273 | screening/baseline | 6 |
| 274 | screening/washout | 3 |
| 275 | side-clamp | 1 |
| 276 | sign-up | 4 |
| 277 | slave-trading | 1 |
| 278 | smartphone-intervention | 1 |
| 279 | softad | 3 |
| 280 | soy-diet | 2 |
| 281 | sparings | 1 |
| 282 | sprinolactone | 1 |
| 283 | stabilisation/screening | 1 |
| 284 | standby | 15 |
| 285 | steroid-stable | 6 |
| 286 | subpatent | 1 |
| 287 | suckling/growing | 1 |
| 288 | survival-free | 1 |
| 289 | switch-back | 4 |
| 290 | tablet-free | 8 |
| 291 | taper/washout | 1 |
| 292 | tapering/initiation | 1 |
| 293 | tapering/washout | 1 |
| 294 | therapy-augmenting | 1 |
| 295 | therapy.superiority | 1 |
| 296 | therapy/waiting | 1 |
| 297 | thie | 2 |
| 298 | titraters | 1 |
| 299 | titration | 1,587 |
| 300 | titration/conversion | 4 |
| 301 | titration/stabilization | 1 |
| 302 | tolerability-assessment | 1 |
| 303 | tot-elicitation | 1 |
| 304 | treatment-extension | 3 |
| 305 | trimethoprim-sulfadiazine | 2 |
| 306 | tzpg | 7 |
| 307 | up-titration | 117 |
| 308 | variable-dose | 12 |
| 309 | videotape/dvd | 2 |
| 310 | vlcd/lcd | 3 |
| 311 | voriconazole-only | 1 |
| 312 | warmth/heat | 2 |
| 313 | wash-in | 14 |
| 314 | wash-out | 404 |
| 315 | wash-out-single-blind | 1 |
| 316 | wash-outs | 1 |
| 317 | washout | 2,219 |
| 318 | washout/dietary | 2 |
| 319 | washout/run-in | 1 |
| 320 | washover | 1 |
| 321 | withdrawal-retreatment | 3 |
| 322 | yom | 5 |
| 1 | gym- | 1 |
| 2 | baseline-1 | 1 |
| 3 | h=1355±51 | 1 |
| 4 | 1968-71 | 1 |
| 5 | pinteraction=0·002 | 1 |
| 6 | pinteraction=0·85 | 1 |
| 7 | pre-pcv7 | 1 |
| 8 | 1970-1989 | 1 |
| 9 | pinteraction=0·99 | 1 |
| 10 | pre-mua | 1 |
| 11 | off-cpb | 1 |
| 12 | ppi/a/c | 3 |
| 13 | non-epidemic | 5 |
| 14 | pneumonitic | 1 |
| 15 | post-enteritic | 1 |
| 16 | dynastic | 1 |
| 17 | esl+oc | 2 |
| 18 | softad | 3 |
| 19 | vlcd/lcd | 3 |
| 20 | coach-administered | 1 |
| 21 | fatigue-adapted | 1 |
| 22 | csa/corticosteroid | 1 |
| 23 | wash-out-single-blind | 1 |
| 24 | videotape/dvd | 2 |
| 25 | n-balance | 4 |
| 26 | dose-maintenance | 8 |
| 27 | point-prevalence | 101 |
| 28 | dysphagia-free | 6 |
| 29 | medicine-free | 3 |
| 30 | ring-free | 2 |
| 31 | survival-free | 1 |
| 32 | pill-free | 13 |
| 33 | clonazepam-free | 1 |
| 34 | contraction-free | 1 |
| 35 | injection-free | 1 |
| 36 | diet-free | 1 |
| 37 | tablet-free | 8 |
| 38 | ''safe | 1 |
| 39 | moche | 1 |
| 40 | interval.the | 2 |
| 41 | thie | 2 |
| 42 | steroid-stable | 6 |
| 43 | omeprazole-bismuth-tetracycline-metronidazole | 1 |
| 44 | omeprazole-clarithromycin-metronidazole | 2 |
| 45 | lag/time | 1 |
| 46 | ofcefotaxime | 1 |
| 47 | mini-volume | 1 |
| 48 | index-volume | 1 |
| 49 | neogene | 2 |
| 50 | no-hygiene | 2 |
| 51 | placebo-baseline | 2 |
| 52 | screening/baseline | 6 |
| 53 | postline | 1 |
| 54 | trimethoprim-sulfadiazine | 2 |
| 55 | regimens-one | 1 |
| 56 | only-one | 1 |
| 57 | period.twenty-one | 1 |
| 58 | ofprednisolone | 1 |
| 59 | sprinolactone | 1 |
| 60 | pre-wildfire | 1 |
| 61 | pre-departure | 4 |
| 62 | bite-increase | 1 |
| 63 | chase | 23 |
| 64 | variable-dose | 12 |
| 65 | inter-dose | 3 |
| 66 | preprolapse | 5 |
| 67 | postmethylphenidate | 2 |
| 68 | 55minute | 1 |
| 69 | 'sensitive | 7 |
| 70 | periopeartive | 1 |
| 71 | qfxbf | 8 |
| 72 | fall-off | 11 |
| 73 | rikkunshito-off | 2 |
| 74 | plaster-on/plaster-off | 1 |
| 75 | 4mg/100g | 1 |
| 76 | jhg | 17 |
| 77 | 1,500mg | 3 |
| 78 | pre-lambing | 1 |
| 79 | birth-spacing | 3 |
| 80 | fructose-loading | 1 |
| 81 | high-loading | 1 |
| 82 | slave-trading | 1 |
| 83 | modification/withholding | 1 |
| 84 | range-finding | 8 |
| 85 | prebonding | 1 |
| 86 | non-brushing | 8 |
| 87 | hiking | 35 |
| 88 | blanking | 29 |
| 89 | postblanking | 1 |
| 90 | postdetailing | 2 |
| 91 | infant-priming | 1 |
| 92 | ifn-γ-priming | 1 |
| 93 | non-cleaning | 1 |
| 94 | gestational/weaning | 3 |
| 95 | run-in/screening | 2 |
| 96 | stabilisation/screening | 1 |
| 97 | peri-training | 1 |
| 98 | mindfulness-training | 2 |
| 99 | detraining | 159 |
| 100 | clofazimine-containing | 3 |
| 101 | ppi-containing | 1 |
| 102 | fq-containing | 1 |
| 103 | dlt-defining | 1 |
| 104 | dose-determining | 2 |
| 105 | pre-running | 1 |
| 106 | reversed-conditioning | 1 |
| 107 | post-warning | 1 |
| 108 | dose-tapering | 2 |
| 109 | drug-discontinuation/tapering | 2 |
| 110 | rewatering | 2 |
| 111 | fixed-dosing | 10 |
| 112 | interdosing | 1 |
| 113 | non-heating | 4 |
| 114 | fumigating | 1 |
| 115 | therapy/waiting | 1 |
| 116 | therapy-augmenting | 1 |
| 117 | suckling/growing | 1 |
| 118 | postmixing | 1 |
| 119 | tzpg | 7 |
| 120 | off-drug | 23 |
| 121 | 24-72-h | 1 |
| 122 | actuations/24-h | 1 |
| 123 | co-synch | 30 |
| 124 | cidr-co-synch | 1 |
| 125 | post-trh | 1 |
| 126 | 1-3-month | 1 |
| 127 | 2-3-month | 1 |
| 128 | 12-24-month | 1 |
| 129 | 1-6-month | 1 |
| 130 | switch-back | 4 |
| 131 | intershock | 1 |
| 132 | postdrink | 1 |
| 133 | left/cathodal | 1 |
| 134 | leuteal | 1 |
| 135 | calcipotrial | 1 |
| 136 | pluvial | 1 |
| 137 | perioperational | 1 |
| 138 | pre-ejectional | 1 |
| 139 | preejectional | 1 |
| 140 | -proportional | 1 |
| 141 | pregnant-puerperal | 1 |
| 142 | peri-/postmenopausal | 1 |
| 143 | internatal | 3 |
| 144 | pre-verapamil | 1 |
| 145 | postcall | 1 |
| 146 | last-known-well | 1 |
| 147 | precontrol | 2 |
| 148 | apr-jul | 1 |
| 149 | pre-tcm | 1 |
| 150 | 63-dim | 2 |
| 151 | 162-km | 1 |
| 152 | pre-bloom | 1 |
| 153 | yom | 5 |
| 154 | prenatal-postpartum | 1 |
| 155 | pre-ban | 1 |
| 156 | republican | 17 |
| 157 | pre-wean | 1 |
| 158 | exposures-when | 1 |
| 159 | lead-in | 318 |
| 160 | phase-in | 2 |
| 161 | wash-in | 14 |
| 162 | run-in | 1,290 |
| 163 | month-run-in | 1 |
| 164 | washout/run-in | 1 |
| 165 | prestudy/run-in | 1 |
| 166 | ppi-clarithromycin-levofloxacin | 1 |
| 167 | bismuth-lansoprazole-amoxicillin-clarithromycin | 2 |
| 168 | leadin | 1 |
| 169 | rbc-clarithromycin-amoxicillin | 1 |
| 170 | 480-min | 1 |
| 171 | lavastatin | 1 |
| 172 | patch-on | 1 |
| 173 | rikkunshito-on | 3 |
| 174 | on/off/on | 2 |
| 175 | biopsy-to-excision | 1 |
| 176 | escalation/expansion | 1 |
| 177 | treatment-extension | 3 |
| 178 | titration/conversion | 4 |
| 179 | preconversion | 7 |
| 180 | noninfusion | 1 |
| 181 | peritransfusion | 1 |
| 182 | interexacerbation | 1 |
| 183 | peri-intubation | 2 |
| 184 | periextubation | 2 |
| 185 | pre-eradication | 2 |
| 186 | andapplication | 1 |
| 187 | post-fumigation | 3 |
| 188 | de-lithiation | 1 |
| 189 | tapering/initiation | 1 |
| 190 | escalation | 777 |
| 191 | continuation/escalation | 1 |
| 192 | embryonation | 1 |
| 193 | titration | 1,587 |
| 194 | re-titration | 1 |
| 195 | dose-titration | 52 |
| 196 | down-titration | 13 |
| 197 | up-titration | 117 |
| 198 | post-titration | 2 |
| 199 | conversion/titration | 2 |
| 200 | depuration | 30 |
| 201 | labilisation | 1 |
| 202 | diet/stabilisation | 1 |
| 203 | precessation | 15 |
| 204 | tot-elicitation | 1 |
| 205 | peri-transplantation | 1 |
| 206 | feed-deprivation | 1 |
| 207 | 12-month-observation | 1 |
| 208 | 30-day-observation | 1 |
| 209 | lipid-stabilization | 1 |
| 210 | titration/stabilization | 1 |
| 211 | postoptimization | 2 |
| 212 | familiarization | 91 |
| 213 | incentivization | 5 |
| 214 | pre-ejection | 239 |
| 215 | pre-ejection/ejection | 1 |
| 216 | preejection | 169 |
| 217 | postrejection | 1 |
| 218 | mono-injection | 1 |
| 219 | fluticasone-reduction | 1 |
| 220 | preoviposition | 1 |
| 221 | smartphone-intervention | 1 |
| 222 | rest/absorption | 1 |
| 223 | post-distribution | 2 |
| 224 | honeymoon | 2 |
| 225 | predawn | 1 |
| 226 | cool-down | 16 |
| 227 | diet+placebo | 4 |
| 228 | diet-plus-placebo | 1 |
| 229 | diet-placebo | 7 |
| 230 | diet/placebo | 15 |
| 231 | 16-mo | 1 |
| 232 | post-asccp | 1 |
| 233 | side-clamp | 1 |
| 234 | dose-ramp | 1 |
| 235 | clmp | 4 |
| 236 | eot-pp | 2 |
| 237 | heating-up | 2 |
| 238 | sign-up | 4 |
| 239 | flow-up | 1 |
| 240 | one-month-follow-up | 1 |
| 241 | post-follow-up | 1 |
| 242 | 2/3-year | 1 |
| 243 | insoluble-fiber | 2 |
| 244 | dependent-manner | 1 |
| 245 | down-taper | 3 |
| 246 | washover | 1 |
| 247 | 35-yr | 1 |
| 248 | bionic-pancreas | 4 |
| 249 | paracetamol/nsaids | 1 |
| 250 | sparings | 1 |
| 251 | during-apheresis | 1 |
| 252 | peri-luteolysis | 1 |
| 253 | off-prophylaxis | 2 |
| 254 | postprophylaxis | 1 |
| 255 | post-surgical/post-rtms | 1 |
| 256 | escalations | 26 |
| 257 | changes/interruptions | 1 |
| 258 | reductions/interruptions | 1 |
| 259 | titraters | 1 |
| 260 | interruptions/adjustments | 1 |
| 261 | wash-outs | 1 |
| 262 | modifications/delays | 1 |
| 263 | warmth/heat | 2 |
| 264 | post-contact | 1 |
| 265 | low-calorie-diet | 2 |
| 266 | soy-diet | 2 |
| 267 | post-soviet | 4 |
| 268 | peri-lt | 1 |
| 269 | pre-omt | 1 |
| 270 | efficacy-assessment | 1 |
| 271 | tolerability-assessment | 1 |
| 272 | randomized-treatment | 1 |
| 273 | hormone-treatment | 2 |
| 274 | withdrawal-retreatment | 3 |
| 275 | observation/retreatment | 2 |
| 276 | dose-adjustment | 19 |
| 277 | subpatent | 1 |
| 278 | prepatent | 19 |
| 279 | id-st | 3 |
| 280 | running-out | 1 |
| 281 | wash-out | 404 |
| 282 | clean-out | 2 |
| 283 | run-out | 15 |
| 284 | washout | 2,219 |
| 285 | drug-washout | 2 |
| 286 | placebo-washout | 4 |
| 287 | screening/washout | 3 |
| 288 | tapering/washout | 1 |
| 289 | run-in/washout | 2 |
| 290 | taper/washout | 1 |
| 291 | lockout | 50 |
| 292 | bare-fallow | 1 |
| 293 | preindex | 15 |
| 294 | postindex | 14 |
| 295 | 200/day | 1 |
| 296 | 10-mg/kg/day | 1 |
| 297 | 20+/-10mg/day | 1 |
| 298 | 12mg/day | 2 |
| 299 | standby | 15 |
| 300 | prepolicy | 4 |
| 301 | postpolicy | 4 |
| 302 | eligibility/study | 1 |
| 303 | 74.4gy | 1 |
| 304 | 68gy | 2 |
| 305 | voriconazole-only | 1 |
| 306 | dependently | 182 |
| 307 | post-adenomectomy | 1 |
| 308 | postsplenectomy | 1 |
| 309 | pericraniotomy | 1 |
| 310 | postcolonoscopy | 2 |
| 311 | post-revolutionary | 1 |
| 312 | placebo/dietary | 2 |
| 313 | washout/dietary | 2 |
| 314 | peri-ovulatory | 5 |
| 315 | first-interovulatory | 1 |
| 316 | ranging/efficacy/safety | 1 |
| 317 | proportionality | 135 |
| 318 | reduction.severity | 1 |
| 319 | therapy.superiority | 1 |
| 320 | aware® | 1 |
| 321 | p4+pgf2α | 2 |
| 322 | pegylated-ifnα | 1 |